This study aims to verify the safety and preliminary clinical benefits of long-term gait training using AI-powered smart electric vehicles for patients with neurodegenerative diseases such as Parkinson's disease and dementia.
Patients with neurodegenerative diseases (such as Parkinson's disease or dementia).
Age between 50-85 years.
Capable of walking for at least 10 meters, but may have unsteady gait or history of falls.
Able to understand the trial procedures and give informed consent.
Severe cardiopulmonary disease or recent major surgery.
Unable to walk or requiring comprehensive physical support.
Severe cognitive impairment preventing understanding of the trial procedures or giving informed consent.
Visual or auditory impairments severe enough to prevent following trial instructions.